Your search for Yondelis returned 106 results

Your search for Yondelis returned 106 results

Sort Results:

Relevant Recent

Did you mean: youngelis

Drug Monograph


Trabectedin 1mg; per vial; lyophilized pwd for IV infusion after reconstitution and dilution; contains sucrose.

Yondelis Approved for Advanced Soft Tissue Sarcoma

The Food and Drug Administration (FDA) has approved Yondelis (trabectedin; Janssen) for the treatment of patients with advanced soft tissue sarcoma (STS), including liposarcoma and leiomyosarcoma subtypes, who have received prior chemotherapy including an anthracycline.

New Drug Product: Yondelis

This slideshow reviews drug information for YONDELIS (trabectedin). Click here for the complete YONDELIS new product monograph. For a downloadable PDF of this slideshow, click here.
Drugs in the Pipeline

Pexidartinib Designated Breakthrough Therapy for Rare Tumor

The FDA has granted Breakthrough Therapy designation to pexidartinib (formerly PLX3397; Daiichi Sankyo/Plexxikon) for the treatment of tenosynovial giant cell tumor (TGCT) where surgical removal of the tumor would be associated with potentially worsening functional limitation or severe morbidity.

RoxyBond Approved for the Management of Severe Pain

Lab tests have also shown RoxyBond to have higher resistance to cutting, crushing, grinding or breaking with selected tools when compared to another oxycodone immediate-release tablet.